Merck to Complete Acquisition of Cidara Therapeutics
Go back to Merck to Complete Acquisition of Cidara Therapeutics| Fidelity Advisor Small Cap independence Fund Class T (NASDAQ: CDTX) | Delayed: 221.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.38 | 52 Week High | $18.07 | |||
| Open | $221.38 | 52 Week Low | $8.65 | |||
| Day High | $221.38 | P/E | N/A | |||
| Day Low | $221.38 | EPS | $0.00 | |||
| Volume | 7,499 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 119.05 -1.71 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.76 | 52 Week High | $65.46 | |||
| Open | $121.50 | 52 Week Low | $47.97 | |||
| Day High | $121.90 | P/E | 80.99 | |||
| Day Low | $118.83 | EPS | $1.47 | |||
| Volume | 8,506,278 | |||||
